Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Carcinoma, Ovarian Epithelial (Phase 2)
Carcinoma, Squamous Cell (Phase 1)
Fallopian Tube Neoplasms (Phase 2)
Hamartoma (Phase 2)
Hepatitis B (Phase 1)
Leukemia, Myeloid, Acute (Phase 1/Phase 2)
Leukemia, Myelomonocytic, Chronic (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Nasopharyngeal Carcinoma (Phase 1)
Neoplasms (Phase 1/Phase 2)
Ovarian Neoplasms (Phase 2)
Peritoneal Neoplasms (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 1)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue